TA1A thymic peptide that modulates immune function by enhancing T-cell maturation and dendritic cell function.
Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from Thymosin Fraction 5 of the thymus gland. It is approved in over 35 countries for treatment of hepatitis B and C, and as an immune adjuvant. Research demonstrates its ability to enhance T-cell differentiation, dendritic cell maturation, and NK cell activity. It acts as an endogenous regulator of innate and adaptive immunity.